Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases.

J Inherit Metab Dis · 2011 · PMC3063559 · PMID 21170681

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

This patient has an increasing trend of anti-Naglazyme IgG antibodies, with a titre of 2,430 at 78 days post-diagnosis and a titre of 7,290 at 177 days post-diagnosis (Figs. 2g -11, 12).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.